An Evaluation of LASIK, SMILE and PRK Surgery in Physicians
Launched by STANFORD UNIVERSITY · Oct 13, 2015
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different eye surgeries—LASIK, SMILE, and PRK—affect the vision and quality of life for doctors and medical students. These procedures are designed to help people see better without glasses or contact lenses, specifically for conditions like nearsightedness, farsightedness, and astigmatism. The researchers want to understand how these surgeries improve daily life and vision from the perspective of those who perform them.
To participate in this study, you need to be at least 21 years old, a physician or medical student, and able to speak and read English. You should not have had any previous eye surgeries and must be considered a good candidate for one of these procedures based on a thorough eye and health evaluation. If you join the trial, you'll need to attend follow-up appointments for a year to track your progress and experiences after the surgery. It's important to note that this study is currently recruiting participants, so if you meet the criteria, you could play a key role in understanding how these eye surgeries can improve vision for healthcare professionals.
Gender
ALL
Eligibility criteria
- • Inclusion criteria.
- • 21 years or older.
- • A physician or medical student.
- • Have the ability to give informed consent.
- • Speak and read English fluently.
- • Have not previously had any form of refractive surgery, including prior LASIK or cataract surgery.
- • May benefit from increased spectacle independence.
- • Have been determined to be a good candidate for the LASIK, SMILE or PRK procedure based on the investigator's assessment of medical and ophthalmic health, general cognitive function, and physical and social limitations.
- • Have a treatment target of bilateral emmetropia.
- • Express willingness and potential ability to return for all follow-up examinations through the 12-month follow-up exam under the care of the treating investigator.
- • Are not enrolled in any other research study.
- • Exclusion criteria.
- • Subjects under the age of 21.
- • Patients with excessively thin corneas.
- • Patients with topographic evidence of keratoconus.
- • Patients with ectatic eye disorders.
- • Patients with autoimmune diseases.
- • Patients who are pregnant or nursing.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Edward E. Manche, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials